Life Extension Magazine

Life Extension Magazine October 2010

Report

Block Absorption of Fat Calories Safely

By Julius Goepp, MD

By Julius Goepp, MD

Vitamin K

Vitamin K

Vitamin K was first discovered for its role in the blood coagulation system. Overt deficiencies in vitamin K produce dangerous bleeding disorders. More recently we’ve learned that vitamin K (like D and E) has a host of other critical functions that are less obvious but no less dangerous. Vitamin K is a crucial factor for enzymes that modify important structural proteins throughout the body.51,52 That makes vitamin K essential for functions in addition to blood clotting, such as bone development, cellular signaling, and growth control, including cancers.52,53 But large segments of the adult population already don’t get adequate vitamin K to support those critical processes.53,54 Further depletion of vitamin K by orlistat, therefore, puts you in danger of losing essential vitamin K-dependent functions.10

Of greatest concern is that vitamin K deficiency (or depletion) is associated both with blood vessel calcification and with osteoporosis.55 That’s because vitamins D and K interact in a delicate ballet to determine where calcium winds up in your body.56 At the right levels, it goes into bone, preventing osteoporosis. But with deficiency of vitamin K, the opposite happens. Calcium leaves bone, instead becoming deposited in arterial walls.56 Indeed, normal cells in the vessel wall transform into bone-forming cells—essentially turning your arteries into bone!57,58 Meanwhile, in bone tissue the effects of vitamin K depletion are the opposite—low K levels are associated with calcium loss, lower bone mass and increased fracture risk.59

 People with high plasma levels of vitamin E were found in 2010 to have reduced incidence of Alzheimer’s disease.

Fortunately, supplementation with the proper form of vitamin K can help prevent consequences of vitamin K depletion. A supplement containing both vitamins D and K had a beneficial effect on the elasticity of arterial walls.60 And in people who already have coronary arterial calcification, vitamin K supplementation can prevent progression of the disease.61 Indeed, high intake of vitamin K2 (menaquinone) is associated with lower overall risk of death from coronary heart disease.62

Vitamin supplementation with menaquinone (K2) is also protective against osteoporosis and fractures.62,63 It helps reduce blood levels of bone-resorption markers and increases markers of bone formation.64 Vitamin K supplementation also enhances overall bone metabolism in active women65 and improves bone geometry and strength in postmenopausal women.66

Summary

omega-3 fatty acids

A groundbreaking study conclusively demonstrated that dieting is not only ineffective; it can also be dangerous. Repeated dieting is a risk factor for cardiovascular disease, stroke, diabetes, and altered immune function.

Life Extension recommends that in lieu of dieting, an effort should be made to adjust one’s food intake to gradually reduce the number of calories ingested each day.

The lipase inhibitor orlistat and the special fiber propolmannan can help facilitate the effects of a modestly reduced fat calorie diet by helping to impede absorption of some fat calories.

Since impeding dietary fats can also reduce absorption of fat-soluble nutrients (including vital omega-3 fatty acids), you should adjust your supplement regiment to make sure you take these nutrients at a time of the day furthest removed from your last dose of orlistat and/or propolmannan.

If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at
1-866-864-3027.

References

1. Mann T, Tomiyama AJ, Westling E, Lew AM, Samuels B, Chatman J. Medicare’s search for effective obesity treatments: diets are not the answer. Am Psychol. 2007 Apr;62(3):220-33.

2. Available at: http://www.physorg.com/news94906931.html. Accessed June 21, 2010.

3. de Castro JJ, Dias T, Chambel P, et al. A randomized double-blind study comparing the efficacy and safety of orlistat versus placebo in obese patients with mild to moderate hypercholesterolemia. Rev Port Cardiol. 2009 Dec;28(12):1361-74.

4. McClendon KS, Riche DM, Uwaifo GI. Orlistat: current status in clinical therapeutics. Expert Opin Drug Saf. 2009 Nov;8(6):727-44.

5. Harp JB. Orlistat for the long-term treatment of obesity. Drugs Today (Barc). 1999 Feb;35(2):139-45.

6. Available at: http://www.myalli.com/About_alli/alli_in_the_body.aspx. Accessed June 16, 2010.

7. Finer N, James WP, Kopelman PG, Lean ME, Williams G. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13.

8. Gotfredsen A, Westergren Hendel H, Andersen T. Influence of orlistat on bone turnover and body composition. Int J Obes Relat Metab Disord. 2001 Aug;25(8):1154-60.

9. O’Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity. Health Technol Assess. 2001;5(18):1-81.

10. MacWalter RS, Fraser HW, Armstrong KM. Orlistat enhances warfarin effect. Ann Pharmacother. 2003 Apr;37(4):510-2.

11. Ozcelik O, Ozkan Y, Karatas F, Kelestimur H. Exercise training as an adjunct to orlistat therapy reduces oxidative stress in obese subjects. Tohoku J Exp Med. 2005 Aug;206(4):313-8.

12. McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy. 2002 Jul;22(7):814-22.

13. McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res. 2002 Jul;10(7):642-50.

14. Stechschulte SA, Kirsner RS, Federman DG. Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med. 2009 Sep;122(9):793-802.

15. Barnard K, Colon-Emeric C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010 Feb;8(1):4-33.

16. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int. 2010 Feb 24.

17. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006 Dec;14(12):1032-40.

18. Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010 Jan 5;74(1):18-26.

19. Annweiler C, Schott AM, Allali G, et al. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology. 2010 Jan 5;74(1):27-32.

20. Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM. Vitamin D deficiency and frailty in older Americans. J Intern Med. 2010 Apr 28.

21. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008 Oct;65(10):1348-52.

22. Bikle DD. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):348-52.

23. Faumuina R, Bilbao J, Aspy CB, Mold JW. Is vitamin D deficiency associated with a greater likelihood of contracting influenza? J Okla State Med Assoc. 2010 Apr-May;103(4-5):118-9.

24. Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E. On the epidemiology of influenza. Virol J. 2008;5:29.

25. Edlich RF, Mason SS, Dahlstrom JJ, Swainston E, Long WB, 3rd, Gubler K. Pandemic preparedness for swine flu influenza in the United States. J Environ Pathol Toxicol Oncol. 2009;28(4):261-4.

26. Herranz Antolin S, Garcia Martinez MD, Alvarez De Frutos V. Vitamin D deficiency in morbidly obese patients. A case-control study. Endocrinol Nutr. 2010 May 20.

27. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev. 2008 Mar;13(1):6-20.

28. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res. 2005 Jan;49(1):7-30.

29. Blum S, Vardi M, Brown JB, et al. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics. 2010 May;11(5):675-84.

30. Shah FD, Patel JB, Shukla SN, Shah PM, Patel PS. Evaluation of plasma non-enzymatic antioxidants in breast cancer etiology. Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):91-6.

31. Zingg JM. Vitamin E: an overview of major research directions. Mol Aspects Med. 2007 Oct-Dec;28(5-6):400-22.

32. Tolle A, Schlame M, Charlier N, Guthmann F, Rustow B. Vitamin E differentially regulates the expression of peroxiredoxin-1 and -6 in alveolar type II cells. Free Radic Biol Med. 2005 May 15;38(10):1401-8.

33. Johnson A, Manor D. The transcriptional signature of vitamin E. Ann N Y Acad Sci. 2004 Dec;1031:337-8.

34. Traber MG, Frei B, Beckman JS. Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr Opin Lipidol. 2008 Feb;19(1):30-8.

35. Melia AT, Koss-Twardy SG, Zhi J. The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers. J Clin Pharmacol. 1996 Jul;36(7):647-53.

36. Sabat R, Guthmann F, Rustow B. Formation of reactive oxygen species in lung alveolar cells: effect of vitamin E deficiency. Lung. 2008 Mar-Apr;186(2):115-22.

37. Huang HS, Ma MC, Chen J. Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney. Am J Physiol Renal Physiol. 2009 Jan;296(1):F34-45.

38. Shimizu MH, Araujo M, Borges SM, de Tolosa EM, Seguro AC. Influence of age and vitamin E on post-ischemic acute renal failure. Exp Gerontol. 2004 May;39(5):825-30.

39. Drew JE, Mercer DK, Mayer C, et al. Oxidative stress in colon tissue induced by vitamin E depletion. Biochem Soc Trans. 2004 Dec;32(Pt 6):979-81.

40. Jiang Q, Christen S, Shigenaga MK, Ames BN. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001 Dec;74(6):714-22.

41. Minamiyama Y, Takemura S, Hai S, Suehiro S, Okada S. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress. Free Radic Biol Med. 2006 Mar 1;40(5):808-16.

42. Jolitha AB, Subramanyam MV, Asha Devi S. Modification by vitamin E and exercise of oxidative stress in regions of aging rat brain: studies on superoxide dismutase isoenzymes and protein oxidation status. Exp Gerontol. 2006 Aug;41(8):753-63.

43. Fukui K, Takatsu H, Shinkai T, Suzuki S, Abe K, Urano S. Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress. J Alzheimers Dis. 2005 Dec;8(3):299-309.

44. Mangialasche F, Kivipelto M, Mecocci P, et al. High plasma levels of vitamin E forms and reduced Alzheimer’s disease risk in advanced age. J Alzheimers Dis. 2010 Apr 22.

45. Yu W, Park SK, Jia L, et al. RRR-gamma-tocopherol induces human breast cancer cells to undergo apoptosis via death receptor 5 (DR5)-mediated apoptotic signaling. Cancer Lett. 2008 Feb 8;259(2):165-76.

46. Ju J, Picinich SC, Yang Z, et al. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis. 2010 Apr;31(4):533-42.

47. Sen CK, Khanna S, Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 2006 Mar 27;78(18):2088-98.

48. Sen CK, Khanna S, Rink C, Roy S. Tocotrienols: the emerging face of natural vitamin E. Vitam Horm. 2007;76:203-61.

49. Dietrich M, Traber MG, Jacques PF, Cross CE, Hu Y, Block G. Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J Am Coll Nutr. 2006 Aug;25(4):292-9.

50. Usoro OB, Mousa SA. Vitamin E forms in Alzheimer’s disease: a review of controversial and clinical experiences. Crit Rev Food Sci Nutr. 2010 May;50(5):414-9.

51. Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev. 2001 Jul;21(4):274-301.

52. Berkner KL. The vitamin K-dependent carboxylase. Annu Rev Nutr. 2005;25:127-49.

53. Kaneki M, Hosoi T, Ouchi Y, Orimo H. Pleiotropic actions of vitamin K: protector of bone health and beyond? Nutrition. 2006 Jul-Aug;22(7-8):845-52.

54. McCann JC, Ames BN. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr. 2009 Oct;90(4):889-907.

55. Okura T, Kurata M, Enomoto D, et al. Undercarboxylated osteocalcin is a biomarker of carotid calcification in patients with essential hypertension. Kidney Blood Press Res. 2010;33(1):66-71.

56. Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008 Oct;100(4):593-603.

57. Krueger T, Westenfeld R, Schurgers L, Brandenburg V. Coagulation meets calcification: the vitamin K system. Int J Artif Organs. 2009 Feb;32(2):67-74.

58. Massry SG, Smogorzewski M. Management of vascular calcification in CKD patients. Semin Nephrol. 2006 Jan;26(1):38-41.

59. Shea MK, Booth SL. Update on the role of vitamin K in skeletal health. Nutr Rev. 2008 Oct;66(10):549-57.

60. Braam LA, Hoeks AP, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost. 2004 Feb;91(2):373-80.

61. Shea MK, O’Donnell CJ, Hoffmann U, et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr. 2009 Jun;89(6):1799-807.

62. Erkkila AT, Booth SL. Vitamin K intake and atherosclerosis. Curr Opin Lipidol. 2008 Feb;19(1):39-42.

63. Iwamoto J, Matsumoto H, Takeda T. Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials. Clin Drug Investig. 2009;29(7):471-9.

64. Vermeer C, Gijsbers BL, Craciun AM, Groenen-van Dooren MM, Knapen MH. Effects of vitamin K on bone mass and bone metabolism. J Nutr. 1996 Apr;126(4 Suppl):1187S-91S.

65. Craciun AM, Wolf J, Knapen MH, Brouns F, Vermeer C. Improved bone metabolism in female elite athletes after vitamin K supplementation. Int J Sports Med. 1998 Oct;19(7):479-84.

66. Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007 Jul;18(7):963-72.